Cincinnati Eye Institute Researchers Provide Details of New Studies and Findings in the Area of Uveitis (Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients)

MLA

“Cincinnati Eye Institute Researchers Provide Details of New Studies and Findings in the Area of Uveitis (Fluocinolone Acetonide 0.18-Mg Implant for Treatment of Recurrent Inflammation Due to Non-Infectious Uveitis: A Case Series of 15 Patients).” Obesity, Fitness & Wellness Week, Oct. 2024, p. 253. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.811277600&authtype=sso&custid=ns315887.

APA

Cincinnati Eye Institute Researchers Provide Details of New Studies and Findings in the Area of Uveitis (Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients). (2024, October 12). Obesity, Fitness & Wellness Week, 253.

Chicago

Obesity, Fitness & Wellness Week. 2024. “Cincinnati Eye Institute Researchers Provide Details of New Studies and Findings in the Area of Uveitis (Fluocinolone Acetonide 0.18-Mg Implant for Treatment of Recurrent Inflammation Due to Non-Infectious Uveitis: A Case Series of 15 Patients),” October 12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.811277600&authtype=sso&custid=ns315887.